Zobrazeno 1 - 10
of 35
pro vyhledávání: '"V. Galbusera"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Minerva pediatrica. 62(3 Suppl 1)
One of the principal duties of a staff nurse working in a NICU is the assistance of the ventilated infants. The management of the endotracheal tube is a key moment in the neonatal care and it is fundamental to prevent the ventilator induced lung inju
Autor:
M, Mencoboni, M, Bergaglio, M, Serra, G P, Ivaldi, S, Tredici, O, Racchi, L, Rebella, V, Galbusera, M, Grosso, B, Faravelli
Publikováno v:
Anticancer research. 27(6C)
Chemotherapy extends life for patients with advanced non-small cell lung cancer (NSCLC). Second-line treatment of NSCLC includes the use of cytotoxic drugs; however, toxicity is of concern. One molecular target for lung cancer is the epidermal growth
Autor:
A. Muzio, M. Serra, M. Botta, R. Carbone, E. Piccolini, Manlio Mencoboni, V. Galbusera, E. Aitini, B. Castagneto, Spigno F, D. Degiovanni, L. Rebella, R. Buosi, L. Giaretto, Oscar Alabiso
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 19(2)
Background The aim of this study was to evaluate the activity and toxicity of pemetrexed and carboplatin combination as first-line chemotherapy in malignant pleural mesothelioma (MPM). Patients and methods Patients with measurable advanced MPM and a
Autor:
Isabel Haro, Enzio Ragg, V. Galbusera, Mónica Fernández-Vidal, Stefania Mazzini, M.C. Bellucci, F. Castro-Roman
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
10 pages, 8 figures.-- PMID: 17603997 [PubMed].-- Supplementary information (Figs. S1-S3, tables S1-S2, 3 pages) available at: http://www.sciencedirect.com/science/MiamiMultiMediaURL/B6WB5-4NX2NKW-1/B6WB5-4NX2NKW-1-1/6701/b67d8856b079eefc5f04ac28c2ef
Autor:
M P, Mencoboni, S, Tredici, M, Varaldo, G, Queirolo, F, Durand, L, Rebella, V, Galbusera, I M, Pannacciulli, R, Ghio
Publikováno v:
Neoplasma. 53(4)
Systemic therapies employed in patients with metastatic renal cell carcinoma (MRCC) include chemotherapy to immunomodulatory cytokines (interleukin 2 [IL-2], interferon alpha [INFalpha]), chemoimmunotherapy, adoptive immune therapy and anti-angiogeni
Autor:
M, Clavio, S, Gatto, G, Beltrami, S, Quintino, L, Canepa, I, Pierri, V, Galbusera, P, Carrara, M, Miglino, R, Varaldo, F, Ballerini, C, Venturino, R, Cerri, M, Risso, E, Balleari, A M, Carella, M, Sessarego, R, Ghio, A, Bacigalupo, M, Gobbi
Publikováno v:
Journal of experimentalclinical cancer research : CR. 21(4)
Forty-three consecutive patients with de novo and untreated non M3 AML aged 60 or less entered the study. The mean age of patients was 50 (range 15-60). The induction regimen (FLAG-Ida) included fludarabine (30 mg/sqm), Ara-C (2 g/sqm) on days 1-5, a
Autor:
Domenico Occhini, C. Di Grazia, Almalina Bacigalupo, Teresa Lamparelli, A M Raiola, M. T. Van Lint, M Podesta, Bénédicte Bruno, V Galbusera, Alida Dominietto, Francesco Frassoni, Francesca Gualandi, Elisabetta Tedone, Stefania Bregante
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 8(12)
We studied the impact of preparative regimens with or without antithymocyte globulin (ATG) on chronic GVHD in 160 patients undergoing marrow transplants from unrelated donors (n = 127) or partially mismatched related donors (n = 33). A conditioning r
Autor:
M, Clavio, S, Quintino, C, Venturino, F, Ballerini, R, Varaldo, S, Gatto, V, Galbusera, A, Garrone, R, Grasso, L, Canepa, M, Miglino, I, Pierri, M, Gobbi
Publikováno v:
Journal of experimentalclinical cancer research : CR. 20(3)
Lymphoplasmacytic-lymphoplasmacytoid lymphoma (LPL)/Waldenstrom's macroglobulinemia (WM) or immunocytoma (IMC) consists of diffuse proliferation of small mature B lymphocytes, plasmacytoid lymphocytes, and plasma-cells. The nosographic definition inc
Autor:
M. Bergaglio, M. Paganuzzi, Rosangela Filiberti, M. Mencoboni, M. Gianola, V. Galbusera, R. Puntoni, G. Tunesi, L. Rebella, M. Serra
Publikováno v:
European Journal of Cancer Supplements. 5:364